-
Press Release
2020/02/20
Abnova Team Up with Chung Yuan Christian University using COVID-19 VLP for Therapeutic Antibody Validation
-
Press Release
2020/02/13
Abnova’s Cell-Surface Vimentin (CSV) Therapeutic Monoclonal Antibody Targeting Wuhan 2019-nCoV Coronavirus
-
Press Release
2020/02/05
Abnova Speed Up Wuhan 2019-nCoV Rapid Test, Therapeutic Antibody and Vaccine Development
-
Press Release
2020/01/31
Abnova Uses Its Rapid DNAx™ Immune Technology for 2019-CoV Wuhan Coronavirus Antibody Production
-
Press Release
2020/01/09
Abnova Signup More Cancer Clinics and Hospitals and Expands its Circulating Tumor Cells and Precision Medicine Business in Japan
-
Press Release
2019/12/19
Abnova Upgrades its Antibody Technology and Manufacturing for Researchers, Biotech and Pharmaceutical Customers Worldwide
-
Conference
2019/12/12
Invited Talk at Investor Conference
-
Conference
2019/11/27
Invited Talk at E-Da Hospital
-
Conference
2019/11/15
Invited Talk at Taiwan Adventist Hospital
-
Press Release
2019/11/13
Abnova Integrates CARlike-IL12 Technology and Setup a IL-12 Patent Portfolio Strategy for Gene Modified T cell Therapy